Immunocore Holdings plc
IMCR
$28.38
-$1.67-5.54%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 310.20M | 296.31M | 280.91M | 265.27M | 249.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 310.20M | 296.31M | 280.91M | 265.27M | 249.43M |
| Cost of Revenue | 14.65M | 55.82M | 46.23M | 31.96M | 11.04M |
| Gross Profit | 295.55M | 240.49M | 234.68M | 233.31M | 238.39M |
| SG&A Expenses | 155.78M | 154.91M | 154.84M | 151.22M | 144.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -18.05M | 897.00K | 897.00K | 897.00K | 897.00K |
| Total Operating Expenses | 362.61M | 365.27M | 355.51M | 337.61M | 309.97M |
| Operating Income | -52.41M | -68.96M | -74.60M | -72.34M | -60.55M |
| Income Before Tax | -52.94M | -53.76M | -59.12M | -65.81M | -60.89M |
| Income Tax Expenses | -1.85M | -6.71M | -4.24M | -5.54M | -5.60M |
| Earnings from Continuing Operations | -51.09 | -47.05 | -54.88 | -60.27 | -55.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.09M | -47.05M | -54.88M | -60.27M | -55.29M |
| EBIT | -52.41M | -68.96M | -74.60M | -72.34M | -60.55M |
| EBITDA | -48.21M | -64.89M | -70.49M | -68.19M | -56.46M |
| EPS Basic | -1.02 | -0.95 | -1.10 | -1.22 | -1.13 |
| Normalized Basic EPS | -0.61 | -0.68 | -0.74 | -0.83 | -0.78 |
| EPS Diluted | -1.03 | -0.95 | -1.10 | -1.22 | -1.13 |
| Normalized Diluted EPS | -0.62 | -0.68 | -0.74 | -0.83 | -0.78 |
| Average Basic Shares Outstanding | 199.96M | 199.45M | 198.56M | 197.24M | 195.55M |
| Average Diluted Shares Outstanding | 202.75M | 202.23M | 203.58M | 202.26M | 200.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
